Previous close | 198.40 |
Open | 202.40 |
Bid | 204.00 x N/A |
Ask | 209.80 x N/A |
Day's range | 202.40 - 202.40 |
52-week range | 178.90 - 291.20 |
Volume | |
Avg. volume | 3 |
Market cap | N/A |
Beta (5Y monthly) | -0.01 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 23 July 2024 - 29 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Biogen's (BIIB) Qalsody is the first therapy approved to treat a rare genetic form of ALS in Europe
Whether to use the 10-day, 21-day, 50-day and other moving averages, the question is, which one is best?